<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ910709-0076</DOCNO><DOCID>910709-0076.</DOCID><HL>   Business Brief -- Duramed Pharmaceuticals Inc.:   NASD Delists Firm's Stock;   Capital Needs Are Blamed</HL><DATE>07/09/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><CO>   DRMD</CO><MS>FINANCIAL (FIN)CONSUMER NON-CYCLICAL (NCY)</MS><IN>DRUG MANUFACTURERS (DRG)SECURITIES (SCR)STOCK MARKET, OFFERINGS (STK)</IN><NS>STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>NORTH AMERICA (NME)OHIO (OH)UNITED STATES (US)</RE><LP>   Duramed Pharmaceuticals Inc., Cincinnati, said its stockwas delisted from the Nasdaq system on Friday by the NationalAssociation of Securities Dealers. The maker of generic drugssaid the action was taken because it failed to meet Nasdaqcapital requirements. Duramed said it's making efforts toaddress the problem.   In the past two years, Duramed has been forced to recallmany of its prescription drugs, either because of variationsfrom batch to batch or because of new interpretations ofrequirements by the Food and Drug Administration.</LP><TEXT/></DOC>